Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)
NCT02260882
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
243
Enrollment
INDUSTRY
Sponsor class
Conditions
Pneumococcal Infection
Interventions
BIOLOGICAL:
PNEUMOVAX™ 23
Sponsor
Merck Sharp & Dohme LLC